Human Anti-MUC17 Recombinant Antibody (
8D12) (V2LY-0725-LY1344)

Lin, S., Ruan, H., Qin, L., Zhao, C., Gu, M., Wang, Z., ... & Wang, J. (2023). Acquired resistance to EGFR-TKIs in NSCLC mediates epigenetic downregulation of MUC17 by facilitating NF-κB activity via UHRF1/DNMT1 complex. International Journal of Biological Sciences, 19(3), 832.

Machado, G. C., & Ferrer, V. P. (2023). MUC17 mutations and methylation are associated with poor prognosis in adult-type diffuse glioma patients. Journal of the Neurological Sciences, 452, 120762.

Layunta, E., Jäverfelt, S., Dolan, B., Arike, L., & Pelaseyed, T. (2021). IL-22 promotes the formation of a MUC17 glycocalyx barrier in the postnatal small intestine during weaning. Cell Reports, 34(7).

Jonckheere, N., Vincent, A., Neve, B., & Van Seuningen, I. (2021). Mucin expression, epigenetic regulation and patient survival: A toolkit of prognostic biomarkers in epithelial cancers. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1876(1), 188538.

Yang, B., Wu, A., Hu, Y., Tao, C., Wang, J. M., Lu, Y., & Xing, R. (2019). Mucin 17 inhibits the progression of human gastric cancer by limiting inflammatory responses through a MYH9-p53-RhoA regulatory feedback loop. Journal of Experimental & Clinical Cancer Research, 38(1), 1-13.

Lin, S., Zhang, Y., Hu, Y., Yang, B., Cui, J., Huang, J., ... & Lu, Y. (2019). Epigenetic downregulation of MUC17 by H. pylori infection facilitates NF-κB-mediated expression of CEACAM1-3S in human gastric cancer. Gastric Cancer, 22, 941-954.

Schneider, H., Berger, E., Dolan, B., Martinez-Abad, B., Arike, L., Pelaseyed, T., & Hansson, G. C. (2019). The human transmembrane mucin MUC17 responds to TNFα by increased presentation at the plasma membrane. Biochemical Journal, 476(16), 2281-2295.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols